CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... ·...

26
CVD Prevention and Treatment During Survivorship: What Lifestyle Changes and How? Susan C. Gilchrist, MD, MS Director, MD Anderson Healthy Heart Program Associate Professor Clinical Cancer Prevention & Cardiology University of Texas MD Anderson Cancer Center

Transcript of CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... ·...

Page 1: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

CVD Prevention and Treatment During

Survivorship: What Lifestyle Changes and How?

Susan C. Gilchrist, MD, MS

Director, MD Anderson Healthy Heart Program

Associate Professor

Clinical Cancer Prevention & Cardiology

University of Texas MD Anderson Cancer Center

Page 2: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Premature Accumulation of Risk Factors in Young Cancer Survivors

Tai, E. Cancer. 2012;118:4884–4891.

0

5

10

15

20

25

30

35

40

45

Smoker Binge

drinker

Obese No PA CVD HTN Disability DM

Risk behaviors Chronic conditions

Survivors of Adolescent and Young Adult Cancer Diagnosed at Ages 15 to 29 Years

Respondents Without a History of Cancer

%

Page 3: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

CV Risk Factors and Major CVD Events in Adult Survivors

of Childhood Cancer

Armstrong GT et al. JCO. 2013; 31:3673-3680.

2+ CV risk factors (RR, 2.4; 95% CI, 1.2 to 4.9)

Page 4: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Causes of Accelerated CVD in Cancer Patients

Decreased Cardiovascular Reserve

SurgeryRadiation

Systemic Therapy

Physical inactivity / changes in body compositionAging

Other CVD risk factors (HTN)

CVRisk Factors

Cancer Diagnosis

Jones, LW. J Am Coll Cardiol. 2007;50:1435-1441.

Direct Effects

Indirect Effects

CVD

Page 5: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Lifestyle and CVD Prevention in Cancer

Page 6: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Exercise and Risk of Major CVD Events in Adult Survivors of

Hodgkin Lymphoma

Jones, LW. JCO. 2014; 32:3643-3650.

Page 7: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Exercise and Survival After Breast Cancer

Ibrahim, EM. Med Oncol (2001) 28:753-765.

≥8 MET-hr-wk

≥ 15 MET-hr-wk

Page 8: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Table 1: Systematic Reviews on the Effect of Exercise Training on VO2 in Cancer Patients (2005-2015)

Study Cancer Type Studies Reviewed

(studies measuring ∆ V02)

Timepoint of Intervention

(studies measuring ∆ V02)

Effect of ET on VO2

Singh et al.,

2013[66]

lung (61%), colorectal,

prostate, colon, pancreatic,

liver, colon, rectum,

sarcoma, esophagus

Systematic review of 18

clinical trials. (6)

Pre-surgical. ↑

Loughney et al.,

2015[101]

Breast (82%), lung, mixed Systematic review of 17

cliical trials. (4)

During cancer treatment. ↔

Schmitz et al.,

2005[68]

Breast (72%), colon, lung,

ovarian, leukemia,

lymphoma, testicular,

sarcoma, stomach,

prostate, other

Systematic review of 22

high-quality studies. (9)

During (5) and after (4)

cancer treatment.

↑ (weak evidence, during)

↑(strong evidence, after)

Jones et al.,

2011[102]

Breast (67%), lymphoma,

prostate, colon

Meta-analysis of 6 clinical

trials. (6)

During (2) and after (4)

cancer treatment.

Wolin et al.,

2010[103]

Hematologic cancer

(100%)

Review of 23 high-quality

intervention studies in adults

and pediatric population.

Adults (1) Children (6)

Receiving and not receiving

hematopoietic stem cell

transplantation.

↑ (weak evidence, adults)

↑(strong evidence, children)

Fong et al.,

2012[72]

Breast (65%), colorectal,

endometrial, prostate,

lung, lymphoma, gastric,

colon, gynecologic

Meta-analysis of 34

randomized clinical trials.

(7)

After cancer treatment. ↑

Effects of Exercise Training on Fitness Across the Cancer

Continuum (2005-2015)

Page 9: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

A Cardiologist’s How To:

Exercise and Risk Factor Change in Cancer Patients

• When

– Prior to

treatment

– During

treatment

– Survivorship

• Where

– Physical therapy

– Oncology

rehabilitation

– Cardiac

rehabilitation

– Community centers

– Home-based

• How

– Referral

– Testing

– Exercise

prescriptions

Page 10: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Cardiac Rehabilitation as a Model for

Cancer Patients

Page 11: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Expanding Components of CR to Cancer Patients

Dalal, HM. BMJ. 2015; 351:h5000.

Page 12: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

PT consult

Flow to Cardiac Rehabilitation for Cancer Patients

Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.

Complete

Chemotherapy

Trigger EPIC

consults

Cardiac Rehab

Cardiology

consult

Functional

evaluation

Page 13: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Preventative Cardiology Consultation

• Goal of the consultation is to assess fitness and CVD risk factors

after cancer treatment.

• Provides patients with a personalized exercise routine.

• Patients also receive information regarding risk of heart disease and

ways to improve your heart health over a lifetime.

Page 14: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Suggested Components of Consultation

• The patient’s evaluation will include a heart risk screening exam

and a treadmill exercise test.

• Impact of prior cancer treatment on heart health

• Fitness level

• Cholesterol levels

• Risk of hypertension or high blood pressure

• Risk of Diabetes

• Body weight and waist measurements

• Impact of family history on heart health

• Smoking cessation information, if needed

Page 15: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Cardiopulmonary Exercise Testing

1. Measure VO2 -Cardiorespiratory Fitness2. Determine Cardiopulmonary Safety 3. Determine Exercise Dose4. Compare Fitness Level to Healthy Age-Sex

Matched Individuals5. Assess Etiology of Shortness of Breath

Page 16: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Contraindications/Special Considerations Prior to Exercise in

Cancer Patients

Cardiac

Uncontrolled symptomatic heart failure

Acute myocarditis

Recent myocardial infarction

Severe symptomatic valvular disease

Uncontrolled heart rhythm

Acute pulmonary embolism

Severe hypertension (>200/110 mmHg)

Lab measures

Severe anemia (<8 g/dl)

Absolute neutrophil count <500

Platelet count <50 k/cmm

Symptoms

Severe shortness of breath

Acute nausea during exercise

Vomiting within 24 hours

Disorientation

Blurred vision

Other

Acute Infection

Acute metabolic disease

Unmanaged lymphedema

Mental or physical impairment to exercise

SPECIAL CONSIDERATIONS

Initial wound healing after surgery

Indwelling catheters

Bone and brain metastasis

Recent chemotherapy or radiation (within 24 hours)

Page 17: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Aerobic Exercise Prescription During Rehabilitation

Intensity(% Max HR)

DurationFrequency

(# /wk)Steps perSession

Minutes per Week

Weeks 1–4 70-85% MHR*Increase from 20 to 30 minutes

Supervised: 2/wk Home: 1/wk

2000-30001.25 x baseline

60–90

Weeks 5–8 70-85% MHRIncrease from 30 to 40 minutes

Supervised: 2/wk Home: 1-2/wk

3000-45001.5 x baseline

120-160

Week 9–12 70-85% MHRContinue 40 minutes

Supervised: 2/wkHome: 2/wk

4500-50002 x baseline

160

* MHR = Maximum heart rate from baseline exercise tolerance test

Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.

Page 18: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Resistance Training Prescription During Rehabilitation

Upper Extremity Lower Extremity

Chest Quadriceps

Back Hamstrings

Shoulder Hip Flexors

Core Hip Extensors

Hip abduction

• The participant resistance training prescription will be based on their experience with resistance training and

modified for any identified range of motion deficits.

• Resistance exercise options targeting different muscle groups will be provided and selected based on initial testing

results.

• After initial oncology treatment the resistance training prescription is two sets of 8-12 repetitions, performed twice

weekly. The initial resistance for chest press and leg press will be set at 60-70% of 1RM for most participants.

Dittus, Lakoski et al. J Cardiopulm Rehabil Prev. 2015 Mar-Apr; 35(2): 130–139.

Page 19: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Patient Example

• 27 year old survivor of AML

(diagnosed 7 years)

• Protocol CCG-2891 (included

anthracycline)

• Relapse

• Re-induction chemotherapy

• Stem Cell transplant 1997

• 2018 Echocardiogram: LVEF 53%

• Hypertension on Azor 10-40mg daily

– BP 120/78

• Insulin resistance on Metformin

– HbA1c 5.2%

• BMI 36 kg/m2

• Inconsistent exerciser

• Non-smoker

• No premature FH of CHD

• Cholesterol levels: LDL 153, HDL

34, TC 208

Page 20: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Case Example: CPET

(26 year old male s/p treatment for AML)

Page 21: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

CVD Prevention Plan

• Blood Pressure

• Insulin resistance

• Cholesterol

• Exercise – Fitness

• Body Weight

• Psychosocial

Page 22: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Conclusion

• CVD risk factor modification is key to preventing CVD in cancer

patients.

• Exercise improves fitness and survival among cancer patients.

• Cardiologists can leverage cardiac rehabilitation model to

systematically improve preventative and lifestyle modification for

cancer patients.

Page 23: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of
Page 24: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Questions

Question 1. A 70-year old woman treated with anthracycline-based

chemotherapy for a diagnosis of breast cancer 5 years ago has a 10-year

ASCVD risk of 10%. What is the recommended blood pressure target for

this woman with stage 1 hypertension?

1. <130/80

2. <140/90

3. <150/90

4. No blood pressure target

Page 25: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of

Questions

Question 2: Exercise after a breast cancer diagnosis is associated with all

of the following except:

1. Improved quality of life

2. Reduced Fatigue

3. Improve Survival

4. Improved cardiorespiratory fitness

5. Reduction in breast cancer recurrence

Page 26: CVD Prevention and Treatment During Survivorship: What .../media/Non-Clinical/Files-PDFs... · Effect of ET on VO2 Singh et al., 2013 [66] lung (61%), colorectal, ... • Risk of